Gilead Helps Put African Nation on Path To Eliminate Hepatitis C
Gilead's partnership with the government of Mauritius has helped in the elimination of Hepatitis C in the country. By providing low-cost treatment and working with high-prevalence regions, the company has contributed to the success of patients like James, who is now free from the disease. The government's commitment and public-private partnerships have been instrumental in the progress towards eradicating Hepatitis C in the region.
Gilead's partnership with Mauritius government aiding in the elimination of Hepatitis C
Providing low-cost treatment for Hepatitis C in high-prevalence regions
Success stories like James' recovery after treatment
Government commitment and public-private partnerships leading to progress in eliminating Hepatitis C
- None.
NORTHAMPTON, MA / ACCESSWIRE / May 7, 2024 / James had been free from using drugs for a decade when a routine test at his local health center revealed he had hepatitis C (HCV).
James was one of many people in the island nation of Mauritius to receive a diagnosis. After seeing a surge of cases that mirrored a global trend, the government began searching for solutions and ultimately began a partnership with Gilead.
Gilead started developing curative therapies for HCV more than a decade ago and as part of its efforts to help ensure its medicines reach those who most need them, the company works with governments in regions of high prevalence around the world to provide low-cost treatment. Public-private partnerships like this are credited with helping James and others find success in treatment and with helping lead to the elimination of HCV.
"Five years back, it was impossible for the country to get these medications," says Dr. Kailesh Jagutpal, Mauritius' Minister of Health and Wellness. "If you have this level of commitment within the government, the elimination of hepatitis C in this region is possible."
James, now in his mid-60s, has finished his treatment and is doing well. Mauritius, meanwhile, is on track to be rid of viral hepatitis within the decade.
Originally published by Gilead Sciences
View additional multimedia and more ESG storytelling from Gilead Sciences on 3blmedia.com.
Contact Info:
Spokesperson: Gilead Sciences
Website: https://www.3blmedia.com/profiles/gilead-sciences
Email: info@3blmedia.com
SOURCE: Gilead Sciences
View the original press release on accesswire.com
FAQ
<p>How is Gilead helping in the elimination of Hepatitis C?</p>
Gilead is providing low-cost treatment and working with high-prevalence regions like Mauritius to eliminate Hepatitis C.
<p>What is the impact of the partnership between Gilead and the government of Mauritius?</p>
The partnership has contributed to the success of patients like James, who is now free from Hepatitis C, and is on track to eliminate the disease in the country.
<p>Who is Dr. Kailesh Jagutpal?</p>
Dr. Kailesh Jagutpal is the Minister of Health and Wellness in Mauritius, who highlights the government's commitment to eliminating Hepatitis C in the region.
<p>What is the goal for Mauritius in terms of Hepatitis C elimination?</p>
Mauritius aims to be rid of viral hepatitis within the decade with the help of initiatives like Gilead's low-cost treatment program.
